JP2023554379A5 - - Google Patents

Info

Publication number
JP2023554379A5
JP2023554379A5 JP2023536343A JP2023536343A JP2023554379A5 JP 2023554379 A5 JP2023554379 A5 JP 2023554379A5 JP 2023536343 A JP2023536343 A JP 2023536343A JP 2023536343 A JP2023536343 A JP 2023536343A JP 2023554379 A5 JP2023554379 A5 JP 2023554379A5
Authority
JP
Japan
Prior art keywords
seq
amino acids
ankyrin repeat
binding protein
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023554379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/086331 external-priority patent/WO2022129428A1/en
Publication of JP2023554379A publication Critical patent/JP2023554379A/ja
Publication of JP2023554379A5 publication Critical patent/JP2023554379A5/ja
Pending legal-status Critical Current

Links

JP2023536343A 2020-12-16 2021-12-16 組換えcd3結合タンパク質及びそれらの使用 Pending JP2023554379A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063126356P 2020-12-16 2020-12-16
US63/126,356 2020-12-16
EP20216705 2020-12-22
EP20216705.2 2020-12-22
US202163182394P 2021-04-30 2021-04-30
US63/182,394 2021-04-30
PCT/EP2021/086331 WO2022129428A1 (en) 2020-12-16 2021-12-16 Recombinant cd3 binding proteins and their use

Publications (2)

Publication Number Publication Date
JP2023554379A JP2023554379A (ja) 2023-12-27
JP2023554379A5 true JP2023554379A5 (enExample) 2024-12-16

Family

ID=79282877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536343A Pending JP2023554379A (ja) 2020-12-16 2021-12-16 組換えcd3結合タンパク質及びそれらの使用

Country Status (9)

Country Link
US (1) US20240052033A1 (enExample)
EP (1) EP4263608A1 (enExample)
JP (1) JP2023554379A (enExample)
KR (1) KR20230120139A (enExample)
AU (1) AU2021403658A1 (enExample)
CA (1) CA3202296A1 (enExample)
IL (1) IL303629A (enExample)
MX (1) MX2023007067A (enExample)
WO (1) WO2022129428A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4149959A1 (en) 2020-05-14 2023-03-22 Molecular Partners AG Multispecific proteins
IL305677A (en) 2021-03-09 2023-11-01 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
EP4447990A1 (en) 2021-12-14 2024-10-23 Molecular Partners AG Designed repeat domains with dual binding specificity and their use
EP4724486A1 (en) 2023-06-06 2026-04-15 Molecular Partners AG Recombinant cd2 binding proteins and their use
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026093563A2 (en) 2024-10-31 2026-05-07 Molecular Partners Ag Multispecific binding proteins and their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5291279B2 (ja) 2000-09-08 2013-09-18 ウニヴェルジテート・チューリッヒ 反復モジュールを含む反復タンパク質の集合体
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
CN113278077A (zh) 2010-11-26 2021-08-20 分子组合公司 设计的与血清白蛋白结合的重复蛋白
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
BR112017020986A2 (pt) 2015-04-02 2018-08-14 Molecular Partners Ag. proteínas de ligação recombinantes e seu uso
CN121499810A (zh) * 2018-09-28 2026-02-10 剑桥企业有限公司 疫苗和方法
CN114222757A (zh) * 2019-06-04 2022-03-22 分子伴侣公司 重组4-1bb结合蛋白及其用途
JP7611173B2 (ja) * 2019-06-04 2025-01-09 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換えfap結合タンパク質及びそれらの使用

Similar Documents

Publication Publication Date Title
JP2023506765A5 (enExample)
JP2023528207A5 (enExample)
JP2019531093A5 (enExample)
JP2021534798A5 (enExample)
JP2023544834A5 (enExample)
JP2023504914A5 (enExample)
JP2018522563A5 (enExample)
JP2020537644A5 (enExample)
JP2024509241A5 (enExample)
JP2023505492A5 (enExample)
JP2013513377A5 (enExample)
JP2008525033A5 (enExample)
JP2023538422A5 (enExample)
JP2010534486A5 (enExample)
JP2002500886A5 (enExample)
JP2018504112A5 (enExample)
JP2023553697A5 (enExample)
JP2025504625A5 (enExample)
NO20025153D0 (no) FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1
JP2024513559A5 (enExample)
JP2024502479A5 (enExample)
JP2024520868A5 (enExample)
JP2006506942A5 (enExample)
JP2024508683A5 (enExample)
JP2019535321A5 (enExample)